Panome Bio
PrivateLast Round
Series A
Mar 15, 2023
Total Funding Raised
$6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Panome Bio is a biotechnology company that provides multi-omics services, including next-generation metabolomics, proteomics, and transcriptomics, to support research in disease and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panome Bio Comparables
Compare Panome Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapient | 88% | |
| Creative Proteomics | 82% | |
| Arome Science Inc. | 80% |
Panome Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2023 |
Panome Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioGenerator Ventures | Series A |
| Telegraph Hill Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 46% MoM.
- Feb 25, 2026
Launched MassID, a cloud-based platform for metabolomics data.
Panome Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Panome Bio's valuation, stock price, and market status.
Is Panome Bio a public or private company?
Panome Bio is a private company.
What is the current stock price of Panome Bio?
Panome Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Panome Bio worth (valuation)?
Valuation information for Panome Bio is not publicly available.
Can I buy Panome Bio stock?
Panome Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panome Bio's last funding round?
Panome Bio's most recent funding round was Series A on March 15, 2023.
Who are the main investors in Panome Bio?
Key investors in Panome Bio include Telegraph Hill Partners.
Will Panome Bio IPO soon?
No public IPO plans have been announced for Panome Bio.
How can I track Panome Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panome Bio's secondary market activity and sign up for updates.